How long does Methcathinone last?

The total duration of Methcathinone via oral is 4 hours to 6 hours.

Methcathinone — SubstanceWiki

Psychoactive stimulant

Methcathinone /ˌmɛθˈkæθɪˌnoʊn/ (α-methylamino-propiophenone or ephedrone) (sometimes called "cat" or "jeff" or "catnip" or "M-Kat" or "kat" or "intash") is a monoamine alkaloid and psychoactive stimulant, a substituted cathinone. It is used as a recreational drug due to its potent stimulant and euphoric effects and is considered to be addictive, with both physical and psychological withdrawal occurring if its use is discontinued after prolonged or high-dosage administration. It is usually snorted, but can be smoked, injected, or taken orally.

Methcathinone is listed as a Schedule I controlled substance by the Convention on Psychotropic Substances and the United States' Controlled Substances Act, and as such it is not considered to be safe or effective in the treatment, diagnosis, prevention, or cure of any disease, and has no approved medical use. Possession and distribution of methcathinone for the purpose of human consumption is illegal under any/all circumstances in the United States and is either illegal or highly regulated in most jurisdictions worldwide.

How It Feels

Methcathinone, known on the street as Cat, arrives with the eager rush of a stimulant that has something to prove. Within minutes of insufflation, a warm, confident euphoria surges upward through the body and into the mind. The heart accelerates, the pupils widen, and there is a sudden, powerful sense that the world has become a friendlier, more exciting, more manageable place. The rush is genuine and pronounced, more rewarding than many cathinones and carrying a quality of warmth and engagement that hints at serotonergic involvement alongside the dopaminergic core.

At the peak, which arrives rapidly and establishes itself within fifteen to thirty minutes, methcathinone delivers its signature combination of euphoria and energized sociability. Conversation feels effortless and deeply engaging. Confidence surges. Physical energy increases dramatically, and there is a powerful desire to move, talk, dance, or simply engage with whatever is happening. Music sounds extraordinary, and there is an emotional openness that, while less pronounced than MDMA, gives social interactions a warmth and depth they would not ordinarily possess. The mind is alert and racing with ideas that feel brilliant and urgent in the moment.

The body, however, pays a meaningful price for this euphoria. Heart rate and blood pressure are markedly elevated. Jaw clenching is forceful and persistent. Sweating is profuse, and body temperature rises noticeably. Appetite is completely abolished. Vasoconstriction can produce uncomfortable coldness in the extremities, and there is a tremor in the hands that becomes apparent during fine motor tasks. At higher doses, the stimulation can cross the line into anxious, paranoid territory, where the confidence and social warmth give way to suspicion, irritability, and a hypervigilant awareness of every sound and movement.

The duration of insufflated methcathinone is two to four hours for the primary effects, after which the comedown begins in earnest. The crash is proportional to the height of the peak: a rapid deflation of mood and energy, replaced by irritability, restlessness, and a powerful craving to redose. This compulsive quality is one of methcathinone's most dangerous features, as repeated dosing extends the experience while progressively diminishing the euphoria and amplifying the side effects. Sleep after extended use is difficult and unrefreshing. The following day brings fatigue, emotional flatness, and a heavy, gray mood that can persist for twenty-four to forty-eight hours.

Subjective Effects

The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.

Physical Effects

Physical(9)

Appetite suppression— A distinct decrease in hunger and desire to eat, ranging from reduced interest in food to complete d...
Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
Tremors— Involuntary rhythmic shaking of the hands, limbs, or body, ranging from fine tremor to gross shaking...
Vasoconstriction— A narrowing of blood vessels throughout the body that produces sensations of cold extremities, tingl...

Tactile(1)

Tactile enhancement— The sense of touch becomes dramatically heightened, making physical contact feel intensely pleasurab...

Cognitive & Perceptual Effects

Cognitive(15)

Analysis enhancement— A perceived improvement in one's ability to logically deconstruct concepts, recognize patterns, and ...
Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
Cognitive euphoria— A cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as...
Cognitive fatigue— Mental exhaustion and difficulty sustaining thought after intense cognitive experiences, common duri...
Compulsive redosing— An overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maint...

Detection Methods

Standard Drug Panel Inclusion

Methcathinone is a substituted cathinone (synthetic cathinone) that is not included on standard 5-panel or 10-panel immunoassay drug screens. Some extended panels (particularly those marketed for "bath salts" detection) may include cross-reactive antibodies for the cathinone class, but coverage is inconsistent. The structural relationship to amphetamine means some cathinones trigger the amphetamine channel on immunoassays, but this is compound-specific and unreliable for Methcathinone.

Urine Detection

Methcathinone and its metabolites can typically be detected in urine for 2 to 4 days following a single dose. Repeated or binge-pattern use may extend this window to 5 or more days. Primary metabolic pathways involve reduction of the beta-keto group, N-dealkylation, and hydroxylation. The resulting metabolites are excreted renally, often as glucuronide or sulfate conjugates.

Blood and Saliva Detection

Blood detection windows for Methcathinone range from 12 to 48 hours depending on dose and individual metabolism. Plasma concentrations decline rapidly due to extensive distribution into tissues. Oral fluid testing can detect Methcathinone for approximately 24 to 48 hours but is not commonly deployed for synthetic cathinones outside of specialized forensic settings.

Hair Follicle Detection

Hair analysis can detect synthetic cathinones including Methcathinone for up to 90 days. Incorporation into the hair shaft follows standard pharmacokinetic principles for basic amines. However, most commercial hair testing panels do not specifically target Methcathinone, requiring custom LC-MS/MS methods with appropriate reference standards.

Confirmatory Testing

Definitive identification of Methcathinone requires instrumental analysis. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the preferred method for synthetic cathinones due to their thermal lability, which can cause degradation during gas chromatography. GC-MS remains usable but may require derivatization for optimal sensitivity. Reference standards specific to Methcathinone are necessary for quantitative confirmation.

Reagent Testing

Marquis reagent typically produces no reaction or a faint yellow-orange color with Methcathinone. Mecke reagent may show no significant color change. Mandelin reagent can produce a yellow to brown reaction. The lack of strong, characteristic color reactions with common reagents makes cathinone identification by reagent testing alone unreliable. A combination of Marquis, Mecke, Mandelin, and Simon's reagents can help rule out other substance classes but cannot positively confirm Methcathinone.

Interactions

Substance	Status	Note
Atropa belladonna	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Datura	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Diphenhydramine	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Harmala alkaloid	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
MAOI	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Myristicin	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Peganum harmala	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
1,3-Butanediol	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1,4-Butanediol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
1B-LSD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1cP-AL-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1cP-LSD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1cP-MiPLA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1P-ETH-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1P-LSD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
1V-LSD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2-Aminoindane	Caution	Increased cardiovascular strain and neurotoxicity risk
2-FA	Caution	Increased cardiovascular strain and neurotoxicity risk
2-FEA	Caution	Increased cardiovascular strain and neurotoxicity risk
2-FMA	Caution	Increased cardiovascular strain and neurotoxicity risk
2,5-DMA	Caution	Increased cardiovascular strain and neurotoxicity risk
25B-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25B-NBOMe	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25C-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25C-NBOMe	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25D-NBOMe	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25E-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25I-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25I-NBOMe	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25N-NBOMe	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-B	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-B-FLY	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-C	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-D	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-E	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-H	Caution	Increased cardiovascular strain and neurotoxicity risk
2C-I	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-P	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-2	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-21	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-7	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2M2B	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
3-FA	Caution	Increased cardiovascular strain and neurotoxicity risk
3-FEA	Caution	Increased cardiovascular strain and neurotoxicity risk
3-FMA	Caution	Increased cardiovascular strain and neurotoxicity risk
3-FPM	Caution	Increased cardiovascular strain and neurotoxicity risk
3-MMC	Caution	Increased cardiovascular strain and neurotoxicity risk
3,4-CTMP	Caution	Increased cardiovascular strain and neurotoxicity risk
3C-E	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
3C-P	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-AcO-DET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-AcO-DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-AcO-DMT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-AcO-MET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-AcO-MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-FA	Caution	Increased cardiovascular strain and neurotoxicity risk
4-FMA	Caution	Increased cardiovascular strain and neurotoxicity risk
4-HO-DET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-DPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-EPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-MET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-HO-MPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-MMC	Caution	Increased cardiovascular strain and neurotoxicity risk
4F-EPH	Caution	Increased cardiovascular strain and neurotoxicity risk
4F-MPH	Caution	Increased cardiovascular strain and neurotoxicity risk
5-APB	Caution	Increased cardiovascular strain and neurotoxicity risk
5-MeO-DALT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
5-MeO-DiBF	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
5-MeO-DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
5-MeO-DMT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
5-MeO-MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
6-APB	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
6-APDB	Caution	Increased cardiovascular strain and neurotoxicity risk
8-Chlorotheophylline	Caution	Increased cardiovascular strain and neurotoxicity risk
A-PHP	Caution	Increased cardiovascular strain and neurotoxicity risk
A-PVP	Caution	Increased cardiovascular strain and neurotoxicity risk
Acetylfentanyl	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Adrafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
AL-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Alcohol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
ALD-52	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Allylescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Alprazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Amphetamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Armodafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
Ayahuasca	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Baclofen	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Benzodiazepines	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Benzydamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Bromantane	Caution	Increased cardiovascular strain and neurotoxicity risk
Bromo-DragonFLY	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Bufotenin	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Buprenorphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Butylone	Caution	Increased cardiovascular strain and neurotoxicity risk
Caffeine	Caution	Increased cardiovascular strain and neurotoxicity risk
Cake	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Carisoprodol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Clonazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Clonazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Clonidine	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Cocaine	Caution	Increased cardiovascular strain and neurotoxicity risk
Codeine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Cyclazodone	Caution	Increased cardiovascular strain and neurotoxicity risk
Deschloroetizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Desomorphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Desoxypipradrol	Caution	Increased cardiovascular strain and neurotoxicity risk
DET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Dextroamphetamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Dextropropoxyphene	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Diazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Dichloropane	Caution	Increased cardiovascular strain and neurotoxicity risk
Diclazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Dihydrocodeine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DMT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOB	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOC	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOI	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOM	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Efavirenz	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Ephedrine	Caution	Increased cardiovascular strain and neurotoxicity risk
Ephylone	Caution	Increased cardiovascular strain and neurotoxicity risk
EPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Escaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Eszopiclone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
ETH-CAT	Caution	Increased cardiovascular strain and neurotoxicity risk
ETH-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Ethylmorphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Ethylone	Caution	Increased cardiovascular strain and neurotoxicity risk
Ethylphenidate	Caution	Increased cardiovascular strain and neurotoxicity risk
Etizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
F-Phenibut	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Fenethylline	Caution	Increased cardiovascular strain and neurotoxicity risk
Fentanyl	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Flualprazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flubromazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flubromazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flunitrazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flunitrazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Gabapentin	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Gaboxadol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
GBL	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
GHB	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Grayanotoxin	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Heroin	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Hexedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Hydrocodone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Hydromorphone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Ibogaine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Isopropylphenidate	Caution	Increased cardiovascular strain and neurotoxicity risk
Kratom	Caution	Increased cardiovascular strain and neurotoxicity risk
LAE-32	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Lisdexamfetamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Lorazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
LSA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
LSD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
LSM-775	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
LSZ	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
MCPP	Caution	Increased cardiovascular strain and neurotoxicity risk
MDA	Caution	Increased cardiovascular strain and neurotoxicity risk
MDMA	Caution	Increased cardiovascular strain and neurotoxicity risk
MDPV	Caution	Increased cardiovascular strain and neurotoxicity risk
Mephedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Mephenaqualone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Mescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
MET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methadone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Methallylescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methamphetamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Methaqualone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Methiopropamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Methylnaphthidate	Caution	Increased cardiovascular strain and neurotoxicity risk
Methylone	Caution	Increased cardiovascular strain and neurotoxicity risk
Methylphenidate	Caution	Increased cardiovascular strain and neurotoxicity risk
Metizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Mexedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Midazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
MiPLA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Mirtazapine	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Modafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
Morphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
MPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
N-Ethylhexedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
N-Methylbisfluoromodafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
Naloxone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
NEP	Caution	Increased cardiovascular strain and neurotoxicity risk
Nicotine	Caution	Increased cardiovascular strain and neurotoxicity risk
Nifoxipam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
NM-2-AI	Caution	Increased cardiovascular strain and neurotoxicity risk
O-Desmethyltramadol	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Oxiracetam	Caution	Increased cardiovascular strain and neurotoxicity risk
Oxycodone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Oxymorphone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
PARGY-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Pentedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Pentobarbital	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Pethidine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Phenobarbital	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Phenylpiracetam	Caution	Increased cardiovascular strain and neurotoxicity risk
PRO-LAD	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Psilocybin Mushrooms	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increased cardiovascular strain and neurotoxicity risk
SAMe	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other

History

Methcathinone was first synthesized in 1928 in the USA and it was used in the Soviet Union as an antidepressant. It is common in central and eastern Europe, often sold as the more well known mephedrone or synthesized from OTC drugs containing ephedrine or pseudoephedrine.

Methcathinone is comprised of a phenethylamine core featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain containing a beta-ketone group (what is known as a cathinone molecule) with an additional methyl substitution at Rα. It can be thought of as the cathinone homolog of methamphetamine as it has the same general formula, differing only in the addition of a single double bonded oxygen.

Although the effects of methcathinone have not been formally studied on the same level as amphetamines, it is possible to speculate that like other simple substituted cathinone, it most likely acts primarily as a dopamine and norepinephrine reuptake inhibitor. The result of this is an effective increase in the levels of the norepinephrine and dopamine neurotransmitters in the brain by binding to and partially blocking the transporter proteins that normally clear those monoamines from the synaptic cleft. This allows dopamine and norepinephrine to accumulate within the key area of the brain linked to reward and pleasure to extra-endogenous levels, resulting in stimulating, motivatory and euphoric effects.

Neuro toxicity

Illicit methcathinone manufactured using potassium permanganate oxidation of ephedrine or pseudoephedrine has been connected with neurotoxicity caused by manganese poisoning.

Methcathinone, due to its highly addictive nature, can often cause extreme compulsive redosing.

It is strongly recommended that one use harm reduction practices when using this substance.

Internationally, methcathinone is a Schedule I controlled substance under the United Nations 1971 Convention on Psychotropic Substances.

Australia: Methcathinone is a Schedule 9 controlled substance.
Responsible use
Stimulants
Cathinones
Mephedrone
3-MMC
Ethcathinone
Pseudoephedrine
Methcathinone (Wikipedia)
Methcathinone (Isomer Design)
Methcathinone (DrugBank)

H,H,H,H,H,CH3,H

Toxicity & Safety

Methcathinone carries significant toxicity risks, particularly with chronic use or high doses. Stimulant toxicity primarily affects the cardiovascular and nervous systems.

Cardiovascular toxicity: Stimulants increase heart rate, blood pressure, and cardiac workload. This can precipitate arrhythmias, myocardial infarction, aortic dissection, or stroke, particularly in individuals with pre-existing cardiovascular conditions or at very high doses.Neurotoxicity: Chronic stimulant use can damage dopaminergic and serotonergic neurons. The extent of neurotoxicity depends on the specific compound, dose, frequency, and route of administration. Some stimulant-induced neurotoxic changes may be partially reversible with prolonged abstinence.Psychiatric effects: High-dose or chronic stimulant use is associated with stimulant psychosis (paranoia, hallucinations), anxiety disorders, and depression during withdrawal. Sleep deprivation from stimulant use compounds these psychiatric risks.Dependence potential: Methcathinone carries meaningful addiction potential due to dopaminergic reward pathway activation. Tolerance develops to euphoric effects, often leading to dose escalation. Withdrawal primarily involves fatigue, depression, anhedonia, and hypersomnia.Other risks: Bruxism and dental damage, weight loss and malnutrition from appetite suppression, hyperthermia (especially with physical activity), and route-specific damage (nasal septum from insufflation, injection site infections).

It is strongly recommended that one use harm reduction practices when using this substance.

Overdose Information

Stimulant overdose from Methcathinone is a medical emergency primarily involving cardiovascular and neurological toxicity.

Signs of overdose: Extremely rapid or irregular heartbeat, chest pain, severe headache, dangerously elevated body temperature, seizures, agitation progressing to psychosis, confusion, and loss of consciousness.Emergency response:

Call emergency services immediately
Keep the person cool (remove excess clothing, apply cool water)
If seizures occur, protect the head and clear the area of hard objects
If the person loses consciousness, place in recovery position
Do not give the person more stimulants, caffeine, or depressants unless directed by medical professionalsPrevention: Pre-measure doses. Avoid redosing. Stay hydrated (but don't overhydrate). Take breaks from physical activity. Monitor heart rate if possible. Have someone present who can recognize warning signs.

Full	Unknown
Half	Unknown
Zero	Unknown

Methcathinone

Quick Dosage

Dosage

oral

Duration

How It Feels

Subjective Effects

Physical Effects

Physical(9)

Tactile(1)

Cognitive & Perceptual Effects

Cognitive(15)

Pharmacology

Detection Methods

Standard Drug Panel Inclusion

Urine Detection

Blood and Saliva Detection

Hair Follicle Detection

Confirmatory Testing

Reagent Testing

Interactions

History

Harm Reduction

General Principles

Methcathinone-Specific Harm Reduction

Toxicity & Safety

Overdose Information

Dangerous Interactions

Tolerance

Legal Status

Experience Reports (2)

Tips (5)

See Also

References (6)

Frequently Asked Questions